• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: AXONICS MODULATION TECHNOLOGIES, INC. AXONICS; STIMULATOR, ELECTRICAL, IMPLANTABLE, FOR INCONTINENCE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

AXONICS MODULATION TECHNOLOGIES, INC. AXONICS; STIMULATOR, ELECTRICAL, IMPLANTABLE, FOR INCONTINENCE Back to Search Results
Model Number 1601
Medical Device Problem Code Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Code Implant Pain (4561)
Date of Event 04/04/2024
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
Product code (d2b): additional product code qon.Premarket/510(k) # (g4): additional premarket/510(k) # p190006.
 
Event or Problem Description
It was reported that a clinical study patient experienced pain at the trial procedure site.They patient received oxycodone, plexeril, and mobic.The investigator reported this adverse event was procedure related.It was later reported that no further information was available, including the outcome of the incident.The participant exited the clinical study immediately after the trial procedure.
 
Additional Manufacturer Narrative
Block d2b: product code: additional product code qon.Block g4: premarket / 510(k) #: additional premarket / 510(k) # p190006.Block h11: investigation details: the device is not available for analysis; therefore, no physical or visual analysis of the product could be performed.There was no report of a device performance allegation.Based on this investigation, the investigation conclusion code of 'known inherent risk of device' was chosen as the allegation relates to "implant pain" which is addressed in the product labeling and risk documentation.The reported patient symptom(s) are known risk associated with this device type and indicated as such in the instructions for use.
 
Event or Problem Description
It was reported that a clinical study patient experienced pain at the trial procedure site.They patient received oxycodone, plexeril, and mobic.The investigator reported this adverse event was procedure related.It was later reported that no further information was available, including the outcome of the incident.The participant exited the clinical study immediately after the trial procedure.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AXONICS
Common Device Name
STIMULATOR, ELECTRICAL, IMPLANTABLE, FOR INCONTINENCE
Manufacturer (Section D)
AXONICS MODULATION TECHNOLOGIES, INC.
15515 sand canyon ave
irvine CA 92618
Manufacturer (Section G)
AXONICS INC
26 technology dr
irvine CA 92618
Manufacturer Contact
farshad fahimi
4100 hamline avenue north
building c
saint paul, MN 55112
MDR Report Key22668620
Report Number2124215-2025-52113
Device Sequence Number7440196
Product Code EZW
UDI-Device Identifier10810005340059
UDI-Public(01)10810005340059(11)230619
Combination Product (Y/N)N
Initial Reporter StateSC
PMA/510(K) Number
P180046
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2024
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Health Professional,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 02/24/2026
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Lay User/Patient
Device Model Number1601
Device Catalogue Number1601
Device Lot NumberAE1R633790
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 07/09/2025
Supplement Date Received by Manufacturer01/27/2026
Initial Report FDA Received Date07/30/2025
Supplement Report FDA Received Date02/24/2026
Date Device Manufactured06/19/2023
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Other;
Patient SexUnknown
-
-